UnitedHealth Group raised its 2026 earnings outlook and increased diluted EPS guidance to at least $19.50. It also set targets of $502 billion in revenue and $23.5 billion in earnings by 2029, and indicated that share buybacks and AI-driven cost reductions are expected to advance.
UnitedHealth Group raised its 2026 net income outlook and set diluted earnings per share at a minimum of $19.50. It also published a long-term outlook calling for revenue to reach $502 billion and earnings to reach $23.5 billion by 2029.
Third-quarter net income from continuing operations was presented at $4.110 billion, with diluted EPS of $4.56. Management emphasized its ongoing operational and cost management efforts to address medical cost inflation and reimbursement trends.
Factors behind the improved performance included the expansion of value-based care programs in the Optum business and the promotion of AI programs aimed at reducing general and administrative expenses. Risks including the rate of medical cost increases, Medicaid margins and shareholder litigation were said to remain.
The scale of the company's share buybacks and its 2026 and 2029 guidance are being watched as factors that could influence the stock outlook, and may also inform investment decisions comparing the company with other market opportunities.